Somatostatin agonists
US6025372A · kind A · utility
21Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 1998 |
| Grant date | Feb 15, 2000 |
| Priority date | — |
| Expiry date | Apr 1, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Somatostatin agonist compounds of formula I are disclosed: ##STR1## including pharmaceutically acceptable salts and hydrates thereof These compounds are useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome and pain. The compounds are potent with high selectivity toward the receptor subtype 2. Pharmaceutical compositions and methods of treatment are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.